Navigation Links
Stater Bros. Helps Customers Fight the Flu
Date:9/2/2009

n groups and demographics to receive this vaccine. In addition to bringing the flu vaccine to its convenient locations, Stater Bros. is also helping customers get more value for their ever stretched budget through the Company's $4 Generic Prescription Program. Over 300 commonly prescribed medications are $4 for a 30 day supply or $10 for a 90 day supply.

Stater Bros. was founded in 1936 in Yucaipa, California, and has grown steadily through the years to become the largest privately owned Supermarket Chain in Southern California and the largest private employer in both San Bernardino County and Riverside County, with annual sales in 2008 of $3.74 billion. Last year, Stater Bros. contributed over $15 million in support of nonprofit organizations in the communities it serves, with an emphasis on worthy programs that benefit hunger relief, health and nutrition, and education. The Company currently operates 167 Supermarkets, and there are over 19,000 members of the Stater Bros. "Family" of Employees.

STATER BROS. MARKETS...SERVING SOUTHERN CALIFORNIA FAMILIES FOR OVER 73 YEARS

    Contact:
    Susan Atkinson
    Vice President Corporate Affairs
    Stater Bros. Markets
    (909) 733-5038


'/>"/>
SOURCE Stater Bros. Supermarkets
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Stater Bros. Introduces New Healthy Selections Dietitian Program
2. Stater Bros. Raises $501,707 for American Heart Association
3. Stater Bros. Super Rx Pharmacy(SM) Now Offering $4 Generic Prescription Drugs
4. Stater Bros. Raises $200,000 for the Leukemia & Lymphoma Society
5. Stater Bros. Charities Kola Cares for Kids Radiothon Raises $161,300 for Loma Linda University Childrens Hospital
6. Stater Bros. Markets Presents $1,143,000 Check to Muscular Dystrophy Association
7. Stater Bros. Charities, KFRG Radio Stations and Loma Linda University Childrens Hospital Will Present More Than 1,100 Brand-New Bikes to 4th Grade Students!
8. Stater Bros. Campaigns to Fight Heart Disease and Stroke... At All Stater Bros. Supermarket Locations
9. Stater Bros. Raises $339,537 for American Heart Association
10. Stater Bros. Raises $266,429.00 for the Leukemia & Lymphoma Society
11. New Health Corp. Announces the Addition of Hannaford Bros., Kash N Karry and Sweet Bay Supermarkets to its Retail Outlets

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ividualsintheRecommendedPriorityGroups ,, HARRI...rtmentofHealthannouncedtodaytheywillconductthreead...ntersinDelaware,Lancaster,andLehighcountiesonTuesd...administeredforfreetoindividualsintherecommendedta....Thedepartmentasksthatonlyindividualsinthefollowin...
(Date:11/23/2009)...nds appears to cause oxidative DNA damage and to i...study published online November 23 in the Journal...iomethylation was once believed to detoxify inorga...city and potentially its carcinogenicity. , To...ative DNA damage in mice, Michael P. Waalkes, Ph.D...
(Date:11/23/2009)...ren who don,t access health care from the same pla...y more likely to have unmet health care needs comp...shed in the journal Pediatrics . , Studies lik...delivery of quality health care for children, the ...bates about health insurance reform, much of the f...
(Date:11/23/2009)...rst-of-its-kind consensus statement on diabetes su...Surgery . The report illustrates the findings of t...betes Surgery Summit (DSS) -- where an internation...perts agreed on a set of evidence-based guidelines...nd study of gastrointestinal surgery to treat type...
(Date:11/23/2009)...hemo deal with insomnia, study shows , ,...sleep disorders affect more than three-quarters of...early three times higher than that of the general ... more common in younger patients and in those with...ster Medical Center researchers, who assessed slee...
Breaking Medicine News(10 mins):Health News:Pennsylvania Department of Health Announces Additional H1N1 Vaccination Clinics in Delaware, Lancaster, Lehigh Counties 2Health News:Children who lack continuity with a regular health care provider miss needed services 2Health News:Children who lack continuity with a regular health care provider miss needed services 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 4Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 5
...ate program that focuses on the most lethal aspect...f Texas M. D. Anderson Cancer Center with support ...y of Texas System. , The Graduate Program in Canc... The program will be offered through The Universit...
...w COBRA legislation passed and unemployment number...answers about COBRA benefits and the new stimulus ...s consumers a resource into the changes of COBRA,s... on the recent legislation. , ...
...d of Hearing Now Provides Caller ID , , NEW YORK...an evolutionary Caller ID feature through PhoneCap...s. Until now, Hard of Hearing (late/accidental los.... PhoneCaption is now the first and only consumer...
... will be deployed in new Monitors that will detect..., LOS ANGELES, March 26 Pulse-oximeters are the m...xygen and pulse rate and have been in use since th...echnology was invented over 20 years ago and relie...
...Institute of Public Health shows a positive link b...ne) zopiclone in the blood and the chance of being...he study also included drivers who only showed alc...s or sleep-inducing medicines as we have for alcoh...
...acy benefit manager Prime Therapeutics (Prime) ann...rick Gleason, PharmD, FCCP, BCPS, Cathy Starner, P...Journal of Managed Care Pharmacy (JMCP) Award of E...risk for an adverse cardiovascular event. , , Pri...
Other Medicine News:Health News:M. D. Anderson launches graduate program in cancer metastasis 2Health News:COBRA-Answers.com Addresses Consumer Concerns Over COBRA Legislation 2Health News:COBRA-Answers.com Addresses Consumer Concerns Over COBRA Legislation 3Health News:COBRA-Answers.com Addresses Consumer Concerns Over COBRA Legislation 4Health News:American Network, Inc. Offers Revolutionary Service to Hard of Hearing 2Health News:Next Generation Optical Technology Has Potential to Greatly Improve Patient Safety 2Health News:Large users of zopiclone assessed as impaired 2Health News:Prime Pharmacists Recognized by the Journal of Managed Care Pharmacy 2
(Date:11/23/2009)...LASVEGAS,Nov.23/PRNewswire-FirstCall/--CordBloodAm...bloodstemcellpreservationcompany( http://www.cordb...tentialofstemcells,abiologicalinsurancepolicy,tofa...hatanupdatedprogressinterviewwithCEOandco-founderM...rviewisat: http://blip.tv/file/2875811 . ,, Int...
(Date:11/23/2009)...PRINCETON,N.J.,Nov.23/PRNewswire-FirstCall/--Pharm...llmentofCohort2,ledbyitspartnerRoche(SWX:ROG.VX;RO...type1and4patientsintheongoingphase2btrialofRG7128,...forthetreatmentofchronichepatitisCvirus(HCV)infect...independentDataMonitoringCommittee(DMC)ofallavaila...
(Date:11/23/2009)...NOVATO,Calif.,Nov.23/PRNewswire-FirstCall/--Raptor...: RPTP ),todayannouncedresultsfromaPhase2bclinical...rtrate("DRCysteamine")inpatientswithnephropathiccy...ersityofCalifornia,SanDiego("UCSD")GeneralClinical...cokineticsandpharmacodynamicsofasingledoseofDRCyst...
Breaking Medicine Technology:Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 61313 1AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 61313 2AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 61313 3AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 61313 4Misonix Announces New Distribution Agreement For The United Arab Emirates 28UAE 29 6255 1Misonix Announces New Distribution Agreement For The United Arab Emirates 28UAE 29 6255 2Misonix Announces New Distribution Agreement For The United Arab Emirates 28UAE 29 6255 3Custom Spine Launches Pathway AVID and Regent ACP at NASS 6251 1Custom Spine Launches Pathway AVID and Regent ACP at NASS 6251 2
...in sodium injection) were also less likely ...DGEWATER, N.J., Dec 10 Sanofi-aventis,announced t...l hospital,direct medical costs associated with VT...hey were treated with the use of low-molecular wei...) with 97.3% of LMWH patients,receiving Lovenox. P...
...ced leukemia and myelodysplastic, syndrome patien...eting., PRINCETON, N.J., Dec. 10 Celator Pharmac...hase I study of CPX-351, a liposomal,formulation t... and,daunorubicin for the treatment of advanced le...escalation in the study is ongoing, thus far three...
Other Medicine Technology:Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 2Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 3Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 4Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 5Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients 2